FDA.reportPublic FDA data

EMTRICITABINE

Substance profile for UNII G70B4ETF4S, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EMTRICITABINE
Structure render from PubChem CID 60877

Substance Identity#

UNII
G70B4ETF4S
Preferred term
EMTRICITABINE
Registry number
143491-57-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C8H10FN3O3S
Chemical structure for EMTRICITABINE
Structure render from PubChem CID 60877

Chemical And Database Identifiers#

InChIKey
XQSPYNMVSIKCOC-NTSWFWBYSA-N
SMILES
NC1=NC(=O)N(C=C1F)[C@@H]2CS[C@H](CO)O2
RxCUI
276237
PubChem
60877
NCIt
C47509
INN ID
7822

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound60877pubchem.ncbi.nlm.nih.gov/compound/60877
PubChem InChIKey SearchXQSPYNMVSIKCOC-NTSWFWBYSA-Npubchem.ncbi.nlm.nih.gov/#query=XQSPYNMVSIKCOC-NTSWFWBYSA-N
RxNorm276237mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=276237
NCI ThesaurusC47509ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47509
FDA Substance Registration SystemG70B4ETF4Sprecision.fda.gov/uniisearch/srs/unii/G70B4ETF4S

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
ACTIVE INGREDIENTThese highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
ACTIVE INGREDIENTThese highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
ACTIVE MOIETYThese highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
ACTIVE INGREDIENTThese highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20111
ACTIVE MOIETYThese highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20111
ACTIVE INGREDIENTThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20042
ACTIVE MOIETYThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20042
ACTIVE INGREDIENTThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA ® (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE MOIETYThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA ® (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE INGREDIENTThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20042
ACTIVE MOIETYThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20042
ACTIVE INGREDIENTThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE MOIETYThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE MOIETYThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20041
ACTIVE INGREDIENTThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20041
ACTIVE INGREDIENTThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE MOIETYThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
ACTIVE INGREDIENTTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]19
ACTIVE MOIETYTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]19
ACTIVE MOIETYATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
ACTIVE INGREDIENTATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
ACTIVE MOIETYCOMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]11
ACTIVE INGREDIENTCOMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]11
ACTIVE MOIETYEMTRIVA (EMTRICITABINE) CAPSULE EMTRIVA (EMTRICITABINE) SOLUTION [GILEAD SCIENCES, INC.]7
ACTIVE INGREDIENTEMTRIVA (EMTRICITABINE) CAPSULE EMTRIVA (EMTRICITABINE) SOLUTION [GILEAD SCIENCES, INC.]7
ACTIVE MOIETYSTRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
ACTIVE INGREDIENTSTRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
ACTIVE MOIETYTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET [CARDINAL HEALTH]3
ACTIVE INGREDIENTTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET [CARDINAL HEALTH]3
ACTIVE MOIETYTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]3
ACTIVE INGREDIENTTRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]3
ACTIVE MOIETYTRUVADA ACCESS (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]3
ACTIVE INGREDIENTTRUVADA ACCESS (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]3
ACTIVE MOIETYATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
ACTIVE INGREDIENTATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
ACTIVE MOIETYSTRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
ACTIVE INGREDIENTSTRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
ACTIVE INGREDIENTATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
ACTIVE MOIETYATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
ACTIVE INGREDIENTATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
ACTIVE MOIETYATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
ACTIVE INGREDIENTCOMPLERA ACCESS (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
ACTIVE MOIETYCOMPLERA ACCESS (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
ACTIVE INGREDIENTGENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1
ACTIVE MOIETYGENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1